Table 3.

Bi-variable and multivariable Cox- regression analysis for independent predictors of mortality among under-five children with SAM admitted in UOGCSH from 2014 to 2017, Gondar, Northwest Ethiopia(n = 527)

Variables	Event	Censored	CHR, 95% CI	AHR and 95% CI	p-value
Diarrhoea
Yes	31	173	1.66 (0.8–2.69)	1.37 (0.79–2.4)	0.254
No	35	288	1	1
Heart failure
Yes	65	458	1.39 (0.63–3.06)	2.35 (0.91–6.02)	0.07
No	58	427	1	1
Hiv/Aids
Reactive	6	12	6.84 (0.43–19.2)	1.5 (0.45–4.97)	0.507
Non-react	51	281	2.96 (0.46–6.02)	1.6 (0 .75–3.4)	0.215
Unknown	9	168	1	1
Pneumonia
Yes	9	65	0.93 (0.46–1.88)	1.1 (0.5–2.45)	0.8
No	57	396	1	1
Folic acid
Yes	36	346	1	1	0.525
No	30	114	2.4 (1.48–3.9)	1.2 (0.67–2.16)
Anemia(< 11 mg/dl)
Yes	49	221	2.57 (1.46–4.53)	2.37 (1.24–4.51)	0.023*
No	16	226	1	1
Shock
Yes	34	9	19.02 (11.65–31)	7.95 (3.72–16.7)	< 0.001*
No	32	449	1	1
NGT feeding
Yes	44	154	3.35 (2.0–5.61)	1.56 (0.7–2.04)	0.1
No	22	307	1	1
Routine Antibiotics
Yes	24	272	1	1	0.007*
No	42	189	2.46 (1.49–4.07)	2.35 (1.25–4.4)
Iv fluid
Yes	48	77	9.61 (5.58–16.5)	3.21 (1.75–5.88)	< 0.001*
No	18	384	1	1
Blood transfusion
Yes	27	31	6.36 (3.8–10.4)	1.9 (0.93–3.88)	0.077
No	39	430	1	1
Intake of F75
Yes	51	377	1	1	< 0.001*
No	15	84	1.70 (0.95–3.04)	6.58 (2.9–14.68)
Intake F100
Yes	24	315	1	1	< 0.001*
No	42	146	5.27 (3.15–8.79)	3 (1.67–5.41)
Deworming
Yes	5	54	1	1	0.45
No	61	407	1.8 (0.9–9.2)	1.61 (0.46–5.64)
Pulse
Normal	20	243	1	1	0.37
Altered	46	211	2.34 (0.39–3.97)	2.39 (0.24–4.61)

*Significant predictors in the multivariable analysis

HIV/AIDS Human Immune-Virus /Acquired Immune Deficiency Syndrome

NGT Naso Gastric Therapy